Reuters logo
BRIEF-Ignyta updates progress towards NDA submissions
April 27, 2017 / 9:59 PM / 5 months ago

BRIEF-Ignyta updates progress towards NDA submissions

April 27 (Reuters) - Ignyta Inc:

* Ignyta updates progress towards entrectinib dual trk and ros1 NDA submissions

* Ignyta - tracking towards dual NDA submissions in TRK and ros1 in 2018 if supported by clinical data, anticipated us commercial launch in both indications in 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below